Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Balk

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
American Journal of Epidemiology|May 4, 2023
Influence of Neighborhood Social and Natural Environment on Prostate Tumor Histology in a Cohort of Male Health ProfessionalsHari S Iyer, Jane B Vaselkiv, Konrad H Stopsack, et al.
ACS Chemical Biology|April 19, 2013
Discovery of a selective irreversible BMX inhibitor for prostate cancerFeiyang Liu, Xin Zhang, Ellen Weisberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2017
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical TrialMark A Exley, Phillip Friedlander, Nadia Alatrakchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate CancerRana R McKay, Lillian Werner, Elahe A Mostaghel, et al.
JCO Precision Oncology|September 11, 2020
Genomic Resistance Patterns to Second-Generation Androgen Blockade in Paired Tumor Biopsies of Metastatic Castration-Resistant Prostate CancerG Celine Han, Justin Hwang, Stephanie A M Wankowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2025
Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition and persists in castration resistant prostate cancerJude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor GenesCarla Calagua, Miriam Ficial, Caroline S Jansen, et al.
Research Square|February 20, 2025
RNAs anchoring replication complex control initiation and firing of DNA replicationSimone Ummarino, Larysa Poluben, Alex K Ebralidze, et al.
Cancer Research|February 8, 2022
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate CancerFen Ma, Seiji Arai, Keshan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptorsEddy J Chen, Adam G Sowalsky, Shuai Gao, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
American Journal of Epidemiology|May 4, 2023
Influence of Neighborhood Social and Natural Environment on Prostate Tumor Histology in a Cohort of Male Health ProfessionalsHari S Iyer, Jane B Vaselkiv, Konrad H Stopsack, et al.
ACS Chemical Biology|April 19, 2013
Discovery of a selective irreversible BMX inhibitor for prostate cancerFeiyang Liu, Xin Zhang, Ellen Weisberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2017
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical TrialMark A Exley, Phillip Friedlander, Nadia Alatrakchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate CancerRana R McKay, Lillian Werner, Elahe A Mostaghel, et al.
JCO Precision Oncology|September 11, 2020
Genomic Resistance Patterns to Second-Generation Androgen Blockade in Paired Tumor Biopsies of Metastatic Castration-Resistant Prostate CancerG Celine Han, Justin Hwang, Stephanie A M Wankowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2025
Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition and persists in castration resistant prostate cancerJude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor GenesCarla Calagua, Miriam Ficial, Caroline S Jansen, et al.
Research Square|February 20, 2025
RNAs anchoring replication complex control initiation and firing of DNA replicationSimone Ummarino, Larysa Poluben, Alex K Ebralidze, et al.
Cancer Research|February 8, 2022
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate CancerFen Ma, Seiji Arai, Keshan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptorsEddy J Chen, Adam G Sowalsky, Shuai Gao, et al.
Pageof 19